Sainan Gong

No ORCID on file · 2 papers in corpus

observational 2023

The value of serum HE4 and CA125 levels for monitoring the recurrence and risk stratification of endometrial endometrioid carcinoma

Heliyon ·doi:10.1016/j.heliyon.2023.e18016

To evaluate the role of serum human epididymis secretory protein 4 (HE4) and carbohydrate antigen 125 (CA125) levels for predicting and monitoring the recurrence of endometrial endometrioid carcinoma (EEC) and assessing preoperative risk st…

other 2021

Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma

Scientific reports ·doi:10.1038/s41598-021-01263-w

There is no recognized serum biomarker to predict the recurrence of endometrial carcinoma (EC). We aimed to explore serum human epididymis protein 4 (HE4) and cancer antigen 125 (CA125) as the biomarkers to predict and monitor recurrence of…